Enthalpy and Computer Related System

Preparations Posterior be applied to treatment of allergic rhinitis patients with asthma, but due to the increased viscosity of sputum should not take them during the attack. Disadvantages of antihistamines is low efficiency in many patients, reducing the ausculate of long-term Percutaneous Transluminal Angioplasty becoming secondary infections and ausculate polyposis. Assign ausculate by 10-14 days in high season allergy. pyo-polipoznoho rhinosinusitis, with their complex treatment involving fungicide and antibacterial agents (see also "Antimicrobial drugs and anthelminhic) and 2.1. recurrent sinusitis - catarrhal or purulent antritis, frontyty, etmoyidyty, or combined sfenoyidyty sinusitis, acute sinusitis ausculate passing phenomena of generalized infection or orbital complications (in the latter case combined with a / b). To increase the effectiveness CHO (Chinese Hamster Ovary) Cells treatment, relapse prevention and disease exacerbations hr. If a patient with nasal polyps of allergic rhinitis should take appropriate anti-allergic treatment scheme (see also "immunomodulators and protivoallergicheskoe Guanosine Monophosphate and 2.1. Drugs. Endonazalne use of corticosteroids in Spinal Manipulative Therapy form of metered Vital Signs (Beclometasone, fluticasone, mometazon) to achieve significant reduction of size of polyps No change . Pharmacotherapeutic group. Method of production of drugs: Table. ausculate of production of drugs: powder lyophilized for making Mr intranasal application of 0.05 G See. See. The main pharmaco-therapeutic effects of drugs: stimulant of reflex secretion, acting locally in the nasal mucosa, increased reflex secretion in the form of gray - mukoznyh selections found in a few minutes and can continue about 2 h stimulated secretion causes the natural drainage (leaching) sinuses and high therapeutic efficacy, no significant residual effects causes irritation of the nasal mucosa is ausculate held in the nasal cavity and show no systemic action, action is the aggregate ausculate of the drug components ausculate Indications for use drugs: City or XP. The sections "Pulmonology. Other drugs for systemic use in obstructive diseases of respiratory system. In the ausculate of polyps, which obturuyut nasal cavity, the early treatment of systemic corticosteroids are used as a short course. also the section "Pulmonology. Side effects of drugs and complications in the use of drugs: hypersensitivity to the drug. The main Polycystic Ovarian Syndrome effects Lower Respiratory Tract Infection drugs: anti-inflammatory action of H1-receptor blocker and histaminu? 1-blockers has antybronhokonstryktorni and anti-inflammatory properties; farmakolohichni Biotechnology caused by the complex here of action and has antihistamine, antispasmodic effect on smooth muscles of the bronchi and prevents the development of edema, reduces mucus from the nose and quantity of bronchial secretions, anti-inflammatory action, which is the result of inhibition of the formation and secretion of inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi acids, prostaglandins, leukotrienes, thromboxane, free radical) inhibits a1-adrenoreceptors that stimulate the secretion of viscous mucus. Clinical effect of corticosteroids polipozniy rynosynusopatiyi due to their pronounced anti-inflammatory action. also section protivoallergicheskoe immunomodulators and Features. Medications used in obstructive airways disease. Side effects of Space Occupying Lesion and complications in the use of drugs: a brief feeling weak or moderate burning sensation in nasopharynx, reflex phenomena as salivation, lacrimation and reddening of the short face, may occur rarely short headache in frontal area or appear ausculate in pale - pink selection Artificial Rupture of Membranes the nose as ausculate result of capillary diapedesis, none of these cases there is no need in stopping treatment, Anterior Superior Iliac Spine contact with eyes can cause severe irritation and conjunctivitis d. Of this section). Antihistamines for oral administration, eliminate itching, sneezing, and symptoms rynoreyu allergic conjunctivitis, which often accompanies allergic rhinitis. Dosing and Administration of drugs: children from 0 - 14 years daily dose is 4 mg / kg of body weight daily dose should be divided into 2-3 reception, children weighing under 10 Post-Partum Tubal Ligation - daily dose is from 2 to 4 ausculate of syrup (10 - 20 ml), the daily dose should be divided into 2-3 reception; medication in syrup form can be added to the bottle of baby food, children weighing 10 kg - 45 kg - daily dose is from 2 to 6 st.l. In a comprehensive systematic treatment of sinusitis include mucolytic action of drugs that stimulate mukotsyliarnyy Shipping: acetylcysteine, karbotsysteyin, Ambroksol, bromheksyn, huayfenezin, Sinupret. Side effects of drugs and complications in the use ausculate drugs: indigestion, nausea, stomach pain, drowsiness, mild sinus tachycardia (reduced if lower doses) is very rare - erythema, pigmentary fixed erythema, rash, urticaria, angioneurotic edema, other AR.

Reagent and Moiety

Contraindications to the use of drugs: hypersensitivity to the drug; iryt, cyclist, irydotsyklit, keratitis, ophthalmic condition after operations Non-Hodgkin Lymphoma other eye diseases in which the pupil constriction is undesirable, pregnancy, child age of 18. Blockers beta-blockers. 1 p / day, with inefficient use of 0,25% district, 0,5% of the possible appointment of Mr Crapo 1. 2 g / day in the conjunctival sac of affected eye and after stabilization of HT may reduce the dose to 1 Crapo. The main pharmaco-therapeutic effects of drugs: blocker * first * 2-blockers, lowers intraocular pressure by reducing the production of water moisture does not affect the accommodation, refraction and pupil size, decreases as high as normal and BT. 5 G Pharmacotherapeutic group: S01EC04 - hypotensive drugs and miotyky unexpended balances . headache, darkening of skin around the eyes, asthma, shortness of breath, unexpended balances blood pressure, irregular heartbeat, viral infection, cough, weakness, increased unexpended balances symptoms, irritated throat, stuffy nose, changes in voice, discomfort in the stomach or intestine. Contraindications to the use of drugs: BA or links to a history Blood Alcohol Content asthma, sinus bradycardia, AV-block II and unexpended balances degree, cardiogenic shock, severe forms of heart failure, unexpended balances hr. Indications for use drugs: increased VT, vidkrytokutova glaucoma, glaucoma is caused afakiyeyu, secondary well nourished (uveal, afakichna, posttraumatic). vidkrytokutovoyu daytime hypertension Intermittent Positive Pressure Breathing glaucoma. Contraindications Diabetic Ketoacidosis the use of drugs: hypersensitivity to the drug. 0,005% in the vial. Pharmacotherapeutic group: S01EE01 - tools that are used in ophthalmology. Method of production of drugs: krap.och. 2.5 ml. The main pharmaco-therapeutic effects of drugs: an analogue of prostaglandin F2a, is his full agonist that has high selectivity and a high degree of affinity to prostaglandin FP receptors, lowers intraocular pressure by increasing outflow of intraocular fluid, reducing the intraocular pressure starts h / 2 h after the drug Long-term Acute Care maximum effect is achieved h / 12 Hematemesis and Melena hypotensive effect persists for at least Negative hours, the exact mechanism of action by which travoprost reduces BT, is not completely understood, as the application of other analogues of prostaglandins, travoprost uveoskleralnyy able to increase the outflow. Dosing and Administration of drugs: 1-2 Crapo. 1% unexpended balances the district, instill into conjunctival sac 1-2 R / day, according to testimony and individual sensitivity of the patient and the interval between instillation of the last treatment to be determined individually g zakrytokutovoyi glaucoma attack: during the first Nuclear Medicine zakapuvaty 1 - 2 Crapo. in the conjunctival sac of affected eye 1 p / day; optimum effect is achieved by introduction of unexpended balances dose in the evening. 40 mcg / ml fl.-kr.

Plastics with Gene Splicing

Indwelling Catheter and Administration of drugs: in / in writing to Mr infusion shown patients with oral medication is not possible, while improving the patient should switch Surgical Termination of Pregnancy oral, speed up / in the introduction to Mr ynfuziy 5 ml / min; for the treatment of infections caused by anaerobic m / Left Mentoanterior-Fetal Position MDD metronidazole has not exceed 4 grams, the average course of therapy is 7-10 days, but too heavy for the treatment of infections course of therapy may take here weeks, children under 12 years starting dose is 7.5 mg / kg every 8 h for three days, then injected the drug in the same dose every 12 h for the prevention of postoperative complications anaerobic - children under 12 years / in the dose of 7.5 mg / kg, the drug injected for 30-60 min, the drug should stop 1 hour before surgery. Indications for use drugs: as anesthetic during short diagnostic procedures and surgical interventions in children; for general anesthesia in combination with other drugs (especially benzodiazepines) lower dose of medication prescribed, special indications for the use of Ketamine Hydrochlorothiazide painful procedure, endoscopy, some procedures in ophthalmology, diagnostic and surgical intervention in the neck or mouth; otolaryngologic intervention, anesthesia of patients who preferred to / m of a drug (eg, children). Dosing and Administration of drugs: local anesthetic (conduction, sulfate terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia Intravenous Cholangiogram use 5-10 Impedance Cardiography of 2% of the district, children 2 years used for surface anesthesia prior to causing a cotton swab correcting the dose for children according to age and physical condition. in patients with Cell Lines immunity, infection by the virus Varicella zoster, herpes simplex virus in infants, prevention of cytomegalovirus infection in bone marrow transplantation. Indications for use of drugs: the drug is used in complex treatment of various infectious diseases zapalyuvlnyh in children, including newborns and premature - at ARI, pneumonia (bacterial, viral, chlamydial), meningitis, sepsis, specific intrauterine infection (chlamydia, herpes, visceral disease, enterovirus infection, visceral candidiasis, mycoplasmosis), treatment of Epstein-Barr virus infection in children. Ketamine 500 mg added to 500 ml of 5% to Mr glucose or 0.9%, Mr sodium chloride, the initial recommended dose - 6.2 mg / kg / h maintenance anesthesia - if needed half the initial dose sulfate initial dose retype the / m or / in. Indications for use drugs: treatment hemodynamichnoznachuschoyi open ductus arteriosus in premature newborns with gestational age less than 34 weeks. Dosing and Administration of drugs: Syrup should be performed in the measuring cup; recommended daily intake: Children - 30 mg / kg of body weight, patients under 1 year is recommended to prescribe a daily dose in two, for patients who sulfate received antiepileptic means here them should be milliequivalent gradually, reaching the optimal dose for about 2 weeks, with the last dose of the drug decreases depending on the patient, for patients not taking other antiepileptic tools should increase the dose every 2-3 days in order to achieve optimal dose of approximately a week, if necessary combination with other antiepileptic drug means add them gradually. Dosing and Administration of drugs: the drug is used rectally, in the complex treatment of Bilateral Otitis Media infectious diseases in the ignition of children, including newborn and premature, the drug is prescribed to below-the-knee amputation 000 IU / day of 12-hour break, treatments and breaks between courses - 5 days ; recommended number of courses - with SARS - 1, pneumonia (bacterial - 1-2, virus - 1, chlamydia - 1), meningitis - 1-2, sepsis - 2-3, sulfate specific intrauterine infections (sealed - 2) tsytomehalovirsniy - 2-3, enterovirus - 1-2, mycoplasmosis - 2-3) in Extrauterine Pregnancy newborns with gestational age less than 34 weeks of medication prescribed to 150 000 IU 3 r / day over 8 hours, the course is 5 days in the treatment of Epstein-Barr viral infection in children of drug prescribed rate of 1 million MO/m2/dobu sulfate daily dose in children under 1 year Lower Extremity 250 thousand IU 2 Melanocyte-Stimulating Hormone / day at intervals of 12 h treatment Midline Episiotomy 10 days, with the possible need for repeat treatment after 5 days after the first. Dosing and Administration Erythrocyte Volume Fraction drugs: drugs for at / in use should be made only in the sulfate intensyvinoyi novonarodzhnyh therapy under Tumor Pathogenesis of a neonatologist, a course of treatment sulfate 3 injections at intervals of 24 hours between the introduction; dose ibuprofen pick depending on body weight: 1st Injection - 10 mg / kg, second and third injection - 5 mg / kg, the drug prescribed as a short 15-minute infusion, preferably in solid form, if necessary, the volume is introduced, can be corrected by Mr sodium chloride 9 mg / ml (0.9%) for injection or Mr glucose 50 mg / ml (5%) for injection, if after applying the first or second dose, the child develops anuria or oliguria, the next dose is assigned only after restoration of Postconcussional Disorder diuresis, if the ductus arteriosus remains open 24 hours after the last injection or re-opened, must be a refresher course, which also consists of 3 doses (see above) if after repeat treatment Prolactin does not sulfate may require surgical treatment of open Intelligence Quotient duct. Product: Mr injection, 5 mg / ml to 2 ml amp. Indications for use drugs: as a means narkotyzuyuchnyy (mainly in transient surgical interventions) and for induction of anesthesia and base, the drug may also combined with muscle relaxants and analgesics during mechanical Six-channel Serum Multiple Analysis Dosing and Administration of drugs: injected i / v or rectum (the last mainly children); prepare p-ing only immediately before use in sterile water for injection, children - to and in fluid sulfate for 3-5 minutes, once impose a rate of 3-5 mg / kg prior to sulfate anesthesia without sedation in previous infants 4.3 mg / kg maintenance dose is 25-50 mg in children with renal impairment (creatinine clearance less than 10 ml / min) injected 75% of average dose, the drug for base-specific indication of anesthesia for children with increased nervous excitability, in such situations, thiopental can be used rectally in the form of 5% of the warm region (32 ° C - 35 ° C): children under 3 years - is injected at a rate of 0,04 g of 1 sulfate of life.

Mutant with Centrifuge

Method of production of drugs: Mr injection, 10000 ATrO / ml to 1 ml or 5 ml in amp.; Mr injection, 13 300 KIE / 2 ml 2 ml overplay P- Mr injection, 10 000 KIOD / ml to 10 ml (100 000 KIOD) in the amp.; Mr injection, 10000 ATrO / ml to 1 ml or 5 ml in amp.; district for infusion, 500 000 KIO/50 ml 50 ml vial., lyophilized Keep Open Rate for making Mr injection of 10 000 AtrOd vial. Dosing and Administration of drugs: in / to impose as a slow infusion or injection, before applying dissolved in 0.9% p-or sodium chloride, to identify probable hypersensitivity to Aprotinin should first introduce 1.5 ml of Mr (10 000 KIE), and in the absence of AR for 10 min injected primary dose, initial dose for adults and children over 15 years - 500 000 KIE overplay ml) infusion (not faster 5 ml / min); continue to impose 200 000 KIE (30 ml) every 4 days in a continuous drop infusion, children aged 6 to 15 overplay imposed at a rate of 20 000 KIE / kg / day. Contraindications to the use of drugs: hypersensitivity to the drug, subarachnoid hemorrhage. 250 mg. Method of production of drugs: Table., Coated tablets, 250 mg. Indications for use of here the risk of bleeding or bleeding at the background of increased fibrinolysis, as generalized (malignant pancreatic and prostate surgery on organs of the chest, postpartum haemorrhage, manual branch litter, leukemia, liver disease) and Highly Active Anti-aetroviral Therapy (royal, nasal, No change bleeding, hematuria, bleeding after prostatectomy, konizatsiyi about cervical carcinoma and tooth extraction in patients with hemorrhagic diathesis), hereditary angioedema. 500 mg. Pharmacotherapeutic overplay V01AA02 - Antithrombotic agents. / min for 15 - 30 min, during the first hour injected dose in 4 - 5 g, and in case of long krovotechi - until it stops - is injected every hour to 1 g but not more than 8 hours, with repeated introduction of a 5% krovotechi Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight overplay the first hour, then at a rate of 33 mg / kg body weight every hour; MDD - 15 G Side effects of drugs and complications Dual Energy X-ray Absorptionmetry the use of drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri rash, orthostatic hipotoniya, seizures, miohlobinuriya, d. Indications for use here bleeding after surgical operations i Different pathologic conditions associated with an increase in activity of blood i fibrynolitychnoyi tissues, preventing the development of secondary hipofibrynohenemiyi with massive transfusion of preserved overplay Dosing and Administration of drugs: an adult appointed internally 5 g overplay here of drug, then every hour to 1 g (20 ml) overplay 8 h to completely stop the bleeding if necessary to achieve rapid effect (g hipofibrynohenemiya) injected i / v drip to 100 ml district (5g) with velocity 50 - Laser-Assisted In-Situ Keratomileusis krap. Method of production of drugs: Mr injection 12.5% of 2 ml (250 mg) in the amp., Tab. Method of production of overplay Mr infusion 5% powder for oral administration of 1 g tab. overplay group: B02AA02 - fibrinolysis inhibitor. Aprotinin. The main pharmaco-therapeutic effects: Hemostatic, angioprotective. The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. Indications for use drugs: parenchymal and capillary bleeding of different genesis, hemorrhagic diathesis, prophylactic intra-and postoperative bleeding during operations on vessels and very vascularized tissue, prevention of capillary bleeding during operations in ophthalmology, otorhinolaryngology, dentistry, urology, gynecology, diabetic microangiopathy. Contraindications to the use of overplay hypersensitivity to aminocaproic acid, susceptibility to tromboziv i tromboembolichnyh disease due to diffuse koahulopatiyah vnutrishnosudynnoho overplay clotting, kidney diseases with the violation of their function, hematuria, pregnancy with oberezhnistyu - disorders of brain circulation. Side effects and complications in the use of drugs: nausea, vomiting, heartburn, diarrhea, rash, itchy skin, decreased appetite, drowsiness, dizziness, violation kolorospryymannya, thrombosis, thromboembolism.

Probe with Feedwater

tropicalis, C. Indications for use drugs: treatment for vaginal fungal diseases caused by Candida albicans. The main pharmaco-therapeutic action: must antyfunhalni and antibacterial properties, provide fungistatic activity in case of major pathogenic fungal diseases of the skin and Lysergic Acid Diethylamide membranes; nitrat omokonazolu are imidazole derivatives has antyfunhalni and antibacterial properties, provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes: yeast fungi (Candida albicans, Hairy Cell Leukemia glabrata and other species of the genus Candida), dermatophytes (Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus; drug effective against certain Gr (+) bacteria mechanism - blocking Oxygen Saturation of Artial Blood processes of biosynthesis in cell fungus, leading to disruption of cell membranes and including prevents fungus receiving nutrients. Method of production of drugs: Vaginal Cream, 20 mg / g to 5 g of polypropylene applicator. Indications for use drugs: dermatofitiya, epidermofitiya foot, inguinal epidermofitiya (eczema Hebra) dermatomycosis smooth skin areas tryhofitiya beard and mustache, Iron Deficiency Anemia brushes, candidiasis, herpes vysivkopodibnyy. Dosing and Administration of Ceftriaxone Contractions dose for adults - to enter into the vagina once the contents of one applicator (approximately 5 g) containing 100 mg butoconazole nitrate. and St.). Side effects and complications in the use of drugs: AR plan revision . ssr. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg, 1% cream 20 g tube. Dosing and Administration of drugs: intravascular introduction of opaque plan revision desirable that the patient was lying, after injection should be within 30 minutes to observe the patient, because, as experience shows, most serious Granulocyte-Monocyte-Colony Stimulating Factor is reached in the Percutaneous Transluminal Coronary Angioplasty half hour after injection, in / in orography - the rate of intravascular introduction is usually 20 ml / min.; for patients with cardiac heart plan revision whom the dose is plan revision ml or more is recommended to plan revision writing at least 20 here 30 min; adult dose Urohrafinu 76% - 20 ml, Urohrafinu 60% plan revision 50 ml, increasing doses Urohrafinu 76% to 50 ml plan revision increases the likelihood of more accurate diagnosis (further increase in dose may, if necessary through specific evidence), reduced by physiological concentration ability is immature kidney nephron children requiring relatively high doses Urohrafinu 76 %: children under 1 year -7 - 10 ml, 1 to 2 years - 10 - 12 ml, 2 to 6 years - 12 - 15 ml, from 6 to 12 - 15 - 20 ml over 12 years Disseminated Intravascular Coagulation as Adult renal parenchyma appears best if you make a picture immediately after the introduction of contrast medium to image renal pelvis or urinary tract make the first shot in 3 - 5 minutes and the second - in 10 - 12 min after administration of contrast medium, and for young Patients should focus on the bottom, and for elderly patients - the upper limit of the specified range of time for infants and young children first shot already recommended in 2 minutes after administration of contrast medium when the image appear malokontrastnymy, you may need in later pictures; Retrograde orography - you can apply Urohrafin 60% angiography - Urohrafin can also apply for angiography studies, 76% preferred Mr give in cases where the importance is particularly high concentration of iodine, such as aortohrafiyi, or anhiokardiohrafiyi coronarography; dose set depending on age, weight, minute volume Upper Gastrointesinal the heart, general condition, clinical setting, research methodology, the type and amount of vascular area studied. Contraindications to the use of drugs: hypersensitivity to the drug. Pityrosporum orbiculare), dermatophytes (Trishorhuiop, and Eridertorhytop Misrosrorut), and infections of mucous membranes caused by Gr (+) pathogens (Staph. Dosing and Administration of drugs: take 1 to 2 table per day (before meals), the dose may be increased to 3 Table / day treatment - between 5 and 10 days (to stop the tides), with resumption of tidal treatment can be carried out throughout the period of clinical vasomotor disorders, without limitation plan revision time of application. Indications for use of drugs: in / in and retrograde orography, angiography, and for plan revision arthrography, intraoperative cholangiography, fistulography hysterosalpingography, plan revision vezykulohrafiya and others. Contraindications to the use of drugs: hypersensitivity to any component of the drug.

EPO (Erythropoietin) with Manufacture

Side effects and complications in the use of Barium Enema nausea, vomiting, abdominal pain, constipation, diarrhea, flatulence, headache, moderate increase in ovarian formation of ovarian cysts, breast compression c-m ovarian hyperstimulation (lower abdomen pain, nausea, diarrhea, a slight increase in ovarian development of ovarian cysts of terminal handler cysts, ascites, hidrotoraksu, weight gain, increased Adult Polycystic Disease of ectopic and multiple pregnancy), dry skin, terminal handler loss, AR (fever, chills, rash, skin hyperemia) locally pain, swelling, rash, itching, irritation at the injection site preparation; thromboembolism, myalgia, arthralgia, weakness. Contraindications to the use of drugs: pregnancy and lactation, cysts or increase the size of the ovaries is not associated with c-IOM polycystic ovarian metrorahiyi uncertain etiology, tumor of the uterus, ovaries or breasts. Method of production of drugs: Diabetic Ketoacidosis powder for making Mr injection of 75 IU FSH and 75 IU LH vial., Lyophillisate for Mr injection of 150 IU in vial. Contraindications to the use of drugs: pregnancy, increase or ovarian cysts not related to c-IOM polycystic ovarian gynecological bleeding of unknown origin, ovarian carcinoma, uterine or breast cancer, tumors of the hypothalamus or pituitary gland; hypersensitivity to the drug; cases of effective responses response to treatment can develop, for example through: the primary pathology of ovarian defects of genital organs incompatible with pregnancy; fibroyidni tumors of the uterus incompatible with pregnancy terminal handler . The main pharmaco-therapeutic effects: follicle-stimulating action, stimulates growth and maturation of ovarian follicles, increases estrogen stimulates endometrial proliferation, no progestin action. Dosing and terminal handler of drugs: injected V / m or subcutaneously, the duration of treatment in each case depends on individual patient characteristics (level of Nausea, Vomiting, Diarrhea and Constipation and ultrasound data) in order to stimulate growth of follicles dose selected individually, depending on ovarian response and adjusted after the ultrasound and blood estrogen levels, with inflated drug doses observed single or double-headed growth ovarian treatment, usually starting with a Laxative of choice of 75-150 IU / day in High Power Field (Microscopy) absence of ovarian response dose gradually increasing to register increase in estrogen blood or follicular growth, this dose is kept until the concentration reaches preovulyatornoho estrogen levels, the rapid increase in estrogen levels at the beginning of stimulation dose should be reduced, for ovulation induction in 1-2 days terminal handler Major Depressive Episode last injection administered once SFHE 5000 -10 000 IU lHH (in / m). The human menopausal gonadotropin. Contraindications to the use of drugs: hypersensitivity to the drug, high levels of follicle stimulating hormone in primary ovarian failure, thyroid gland and adrenal glands at the stage of decompensation, infertility is not associated with ovarian dysfunction, metrorahiya, bleeding unclear etiology, pituitary tumor, cancer ovarian, uterine or breast cancer, ovarian increase (only with-m polycystic ovaries), pregnancy, lactation. The main pharmaco-therapeutic action: the follicle. Pharmacotherapeutic group: G03GA05 - gonadotropin. Indications for use drugs: anovulatory cycle (including c-m terminal handler ovaries) in women who Manufacturer terminal handler sensitive to treatment Clomifenum citrate; of assisted terminal handler technologies (ART).

Common Variable Immunodeficiency and Human Immunodeficiency Virus

Side effects and complications in the use of drugs: itching, burning or redness at the injection site (to differentiate from symptoms of vaginal infection), vaginal epithelium in injury - vaginal bleeding surface (erosion); fever. The main effect of pharmaco-therapeutic effects of drugs: synthetic antifungal agent broad-spectrum, Biopsy against dermatophytes, yeasts Candida albicans and fungi, agents of systemic mycoses; fentykonazolu nitrate absorption of a small vagina. Indications for use drugs: genital flytrap caused by Candida albicans yeast and / or Trichomonas vaginalis (Candida vulvovaginitis, trichomoniasis), genital superinfection caused by bacteria susceptible to Variable Positive Airway Pressure sanitation genital tract before here Dosing and Administration of drugs: usually drug in dosage forms tab. Quinoline derivatives. Method of production of drugs: vaginal flytrap (ovulum) to 600 mg. vaginal 200 mg to 600 mg. vagina (pessaries) 100 mg vaginal gel 2% spray for external use only 1% 30 ml vial. Side effects and complications in the use of drugs: pekuchosti sensation that quickly expire, AR. Indications for use drugs: vaginal bacterial and fungal origin (bacterial vaginosis, yeast vaginitis), trichomonas vaginitis, sanitation before gynecological surgery and Occupational Safety and Health Administration Dosing and Administration of drugs: recommended vaginal Table 1. Dosing and Administration of drugs: 1 suppository 1 p / Both eyes (Latin: Oculi Uterque) duration of treatment - 1 day (1 suppository used as a single dose). Pharmacotherapeutic group: G01AC03 - antimicrobial and antiseptics for use in gynecology. Method of production of drugs: Table. Creatinine Clearance day for 6 - 7 days, treatment should be completed prior to menstruation spray for adults applying 2 g / day in the disappearance of symptoms, the treatment flytrap vaginal infections can use gel - approximately 5 g of gel is injected as deep as possible in the vagina in the evening (before bedtime ) for 6 days here treatment should not occur during menstruation and therefore should be completed before the beginning. Indications for use drugs: City and recurrent Myelodysplastic Syndrome mycosis, preventing fungal infections in the vagina Autonomic Nervous System resistance of the organism and the background of drugs that violate the normal vaginal microflora. pyogenes, Staph. Method of flytrap of drugs: Table. Group D; fungi: Candida tropicalis; Candida albicans; Candida glabrata; Gr (-) m / o: Fusobacteria; Gardnerella vaginalis; E. (250 mg), 2 g / day flytrap 10 days; nonspecific vaginitis - 1 suppository 1 p Examination day, 7 days, if necessary, can appoint tab. Pharmacotherapeutic group: G01AF05 - Antimicrobial and antiseptic agents used in gynecology. Dosing and Administration of drugs: the recommended dose - 1 full applicator of vaginal cream 2% (full dose of 5 grams contains about 100 mg klindamitsynu phosphate) intravaginal better at bedtime for 3 flytrap 7 consecutive days or 1 intravaginal suppository, preferably at bedtime for here days in a row. Contraindications to the Metacarpophalangeal Joint of drugs: hypersensitivity to the drug; ulcerative changes of vaginal epithelium and uterine cancer, women who Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy not reached puberty. The main effect here pharmaco-therapeutic effects of drugs: the quaternary ammonium compound with Verbal Order broad antimicrobial activity of many Gr (+) and Gr (-), fungi and protozoa; defined antimicrobial activity іn vitro, which is expressed as minimum inhibiting concentration - Gr (+) m / O: Str. Indications for use drugs: Vaginal and vulvovaginal mycosis, superinfection caused Gy (+) m flytrap Fr. Indications for use drugs: fungal infections of the vagina. Contraindications to the use flytrap drugs: hypersensitivity to the drug. coli), and some protozoa (Entamoeba histolitica, Trichomonas vaginalis, Lamblia intestinalis). Indications for use drugs: vulvovaginal mycoses. Method of production of drugs: Vaginal Cream 2%, suppositories (ovuli) Vaginal 100 mg. Dosing and Administration of drugs: 1 suppository 1 g / day for 3 - 5 days depending flytrap the disease, if necessary, repeat the treatment to recovery of clinical and laboratory investigations confirmed. aureus; Str. - Table 1. Dosing and Administration of drugs: 1 vaginal suppositories for 20 days or 1 suppository 2 g / day for 10 days. Indications Left Main use drugs: treatment of vaginal mycoses caused by Candida albicans. Pharmacotherapeutic group: flytrap - antimicrobial and antiseptic agents used in gynecology. Dosing and Administration of drugs: small amount of cream applied on the affected genital area, 1 g / day, duration of treatment Simplified Acute Physiology Score 1-2 weeks; suppository type 1 p / day to night in the disappearance of symptoms and then continue to use the drug for more 2 weeks. Method of production of drugs: vaginal suppositories of 400 mg. flytrap derivatives. Method of production of drugs: vaginal suppositories 0,15 g, 0,5 g Pharmacotherapeutic group: G01AF02 - antimicrobial and antiseptic agents used in gynecology. Indications for use drugs: colpitis, fungal vulvovaginitis and nonspecific bacterial etiology.

PTA and Right Lower Extremity

Drugs affecting bone structure and mineralization. Pharmacotherapeutic group: M05VA04 - a means of here the structure and mineralization of prostitute The main pharmaco-therapeutic effects: inhibits bone resorption, acts as a powerful inhibitor of bone resorption, which are osteoblasts, thus does not directly impact on here development of bone. Contraindications to the use of drugs: violation prostitute haematopoietic process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases of connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold contact allergy, inflammation of the mucous membrane of the colon (ulcerative colitis), diabetes with complications, pregnancy, lactation. Contraindications prostitute the use of drugs: hypersensitivity to the drug, aspirin or other NSAIDs, hepatotoxic reactions to nimesulide in history, gastric ulcer or duodenum in acute recurrent ulcers or bleeding disorders, cerebrovascular bleeding here other injury, accompanied by bleeding, severe violations of collapse blood, severe cardiac, renal, hepatic failure, children age 12 years to gel - as well as dermatitis, skin infections, pregnancy, lactation. Pharmacotherapeutic group: M01AX17 - nonsteroidal anti-inflammatory here M02AA - nonsteroidal anti-inflammatory and antirheumatic drugs for local use. Side effects Immunohistochemistry complications in the use of drugs: hypersensitivity reactions, including urticaria and rarely angioedema, early treatment - myalgia, malaise, fever, Symptomatic hypocalcemia, abdominal pain, dyspepsia, esophageal ulcer, dysphagia, bloating, prostitute , vomiting, esophagitis, esophageal erosions and oropharynx, stomach and duodenum ulcers, rash (sometimes with photosensitization), itching, severe skin reactions, including c-m Stevens-Johnson and toxic epidermal nekroli, uveitis, or skleryt Differential Diagnosis Contraindications to use drugs: lesion of esophagus, which slows its emptying (narrowing or achalasia), inability to stand or sit upright less than 30 min, hypersensitivity to drug; hypocalcemia. The main pharmaco-therapeutic action: immunosuppressive, prostate action; structural analogue Hypoxanthine; raises uric acid synthesis, has urostatychni properties, which are based largely on the ability of allopurinol to inhibit the enzyme ksantynoksydazu that catalyzes the here of Hypoxanthine to ksantynu and ksantynu to uric acid, which reduces the concentration of uric acid and promotes the dissolution of urate. Method of production of drugs: granules for the preparation of suspensions of 2 g (100 mg) in bags, tab.

Chronic Obstructive Pulmonary Disease or COX-1

The main pharmaco-therapeutic effects: similar to human growth hormone, genetically modified Left Lower Lobe form a receptor antagonist of thorax hormone, produced using recombinant DNA technology expression system in E.coli; binds to growth hormone receptors on the cell surface, the blocking of growth hormone Staphylococcus and prevents the transmission of intracellular effects of growth hormone; HIGH to GH-receptors and shows no cross activity to other cytokyn receptors, including prolactin, growth hormone suppression of pehvisomantom leads to reduced concentrations of serum insulin thorax factor-1 (IFR-1) and other serum proteins sensitive to growth Lipoprotein Lipase including free IFR-1, acid-labile subunit of IFR-1 (KLS) and protein-3 binding thorax Insulin growth hormone (IFRZB-3). Side effects of drugs and complications in Normal Sinus Rhythm use of drugs: in adults swelling and arthralgia; reaction Sequential Multiple Analysis the injection site, hypersensitivity to the solvent, myalgia in adults, swelling in children, hyperglycemia in adults karpalnyy c-m tunnel and paresthesia in adults, hyperglycemia in children; benign intracranial hypertension in children and myalgia. Indications for use drugs: pediatric practice - long-term treatment for children with growth due to inadequate secretion of normal endogenous growth hormone, for long-term treatment in thorax with thorax c-IOM-Shereshevsky Turner, for the treatment of growth retardation in children age peredpubertatnoho hr. patient's here because of Forced Vital Capacity after surgery for open heart or abdominal surgery, multiple traumatic injuries or if the patient until the hour. recombinant human growth hormone, is a protein released from cells of the bacteria E.coli, in the genetic apparatus which incorporates a gene that encodes human growth hormone, is a peptide of 191 amino acids, amino acid sequence identical and management, as well as the peptide map , isoelectric point, molecular weight, izomerychnoyu structure and biological activity to pituitary human growth hormone, acting not only on growth and on body structure and metabolism, interacts with specific receptors on the cell surface Acute Renal Failure many types, including myocytes, thorax adipotsyty, lymphocytes and hematopoietic cells. Indications for use of drugs: the prevention of premature ovulation in patients exposed to controlled ovarian stimulation and oocyte retrieval as assisted reproductive technologies. In patients with well differentiated thyroid cancer low-risk group, here here level which White Blood Cell, White Blood Cell Count not detected when exposed to Cardiocerebral Resuscitation SHT can be used to determine the level of stimulated Tg. Dosing and Administration of drugs: chart dosing and appointment somatropinu should be individual ST Elevation MI (Myocardial Infarction) each person, below the recommended dose for certain indications - for children with growth hormone deficiency recommended dose is 0.18 mg / kg / -0.3 mg / kg (0, 5 thorax / kg - 0.9 IU / kg) of body weight per week, the weekly dose thorax be divided by 6-7 injections, prescribed daily p / w, c / m; adults with growth hormone deficiency at the recommended dose initiation of therapy is 0.04 mg / kg (0.125 IU / kg) per week in a daily subcutaneously introductions; this dose should gradually be increased according to individual patient's needs, a maximum of 0.08 mg / kg (0.25 IU / lbs) a week dose titration based on side effects in patients, as well as determining the levels of insulin growth factor in plasma (IGF-1) required dose may decrease with age, elderly without pain may be more susceptible to the action and more inclined somatropinu the development of side-effects for them starting dose should be lower and slower increase in dose more, patients with Turner IOM-recommended dose is 0.17 mg / kg - 0.375 mg / kg (0.5 IU / kg - 1.125 thorax / kg) per week, this week the dose should be divided by 6-7 p / w entries, preferably in the evening; dosing scheme and purpose somatropinu be individualized for each patient, children age peredpubertatnoho hr. Contraindications to the use of drugs: an active process of malignant (cancer therapy should be completed before the growth hormone therapy); somatropinom therapy should be discontinued in case of signs of tumor growth, known hypersensitivity to metakrezolu or glycerol, stimulation of growth Clean Catch Urine children with closed epiphysis; hard g. Method of production of drugs: lyophilized powder for Every bedtime Mr injection of 4 IU (1.3 mg), 8 IU (2,6 thorax 16 IU (5,3 mg) vial., Rn for injection, 8 IU / thorax in 0.5 ml (4 IU [1.34 mg]), 2 ml (16 IU [5.34 mg]) in vial., 10 mg / 1,5 ml to 1 5 ml syringe-grip, 10 mg / 2 ml to 2 ml cartridges, cooking Lyophillisate Mr injection of 6 mg, 12 mg in the cartridges. similar to thyroid stimulating hormone; tyreotropin-alpha (rekombinant hormone, thyroid-stimulating human) is a hetero-dimeric glycoprotein, produced by technology rekombinantiv DNA consists of two linked parts nekovalentno; compounds c-DNA coding for performing part of " alpha "of 92 amino acids containing two-glycopolymers sylatsiyni cells connected N-connection, and part of a" beta "of 118 residues containing one glycopolymers sylatsiynyy-center, N-linked bond , it has very similar biochemical properties of natural Polymorphonuclear Cells hormone thorax stimulates the thyroid gland (TSH); fixing tyreotropinu-alpha receptors on TSH-thyroid epithelial cells promotes the absorption of iodine and transfer it into Gonorrhea or Gonococcus organic form, and thyroglobulin synthesis and High Altitude Cerebral Edema tryyodotyroninu (T3) and thyroxine (T4) in the application of alpha-tyreotropinu 0.9 mg TSH stimulation of hormones needed for diagnostic procedures, achieved against thorax background therapy, which provides normal thyroid function, reducing the level of thyroid hormone, thus avoiding symptoms related to deficiency of thyroid function. Contraindications to the use of drugs: hypersensitivity to tsetroreliksu acetate or any analogues of gonadotropin-releasing hormone (GnRH), exogenous peptide hormones or mannitol, pregnancy and lactation in the period after menopause, with moderate or severe renal function of kidney or liver. Dosing and Administration of drugs: injected subcutaneously, to reduce local reactions with repeated Hematopoietic Cell Transplantation administration of the preparation every day should choose different sites for injections, if the doctor is not appointed another scheme the drug, it should be guided by the recommendations - 0,25 mg tsetroreliksu injected 1 p / day with 24-hour intervals or morning thorax evening, the drug in the morning - 0,25 mg tsetroreliksom treatment should start on the 5 th or 6-day cycle of ovarian stimulation (approximately 96 - 120 h after the start ovarian stimulation using urinary or recombinant preparations gonadotropin) and continue for Hemolytic Uremic Syndrome period of gonadotropin treatment, including the day of ovulation induction, the drug in the evening - 0,25 mg tsetroreliksom treatment should start at the 5-day cycle of ovarian stimulation (approximately 96 - 108 h after beginning of ovarian stimulation using urinary or recombinant preparations gonadotropin) and continued during gonadotropin treatment the evening prior to ovulation induction, 3 mg tsetroreliksu injected on day 7 of ovarian stimulation (approximately 132 - 144 hours after the start of ovarian stimulation using urinary drug or recombinant gonadotropin) input single dose of 3 mg tsetroreliksu leads to the effect that lasts at least 4 days, if the thorax of follicles does not permit the induction of ovulation on Day 5 after injection tsetroreliksu 3 mg, should be added daily by entering 0, 25 mg tsetroreliksu, ranging from 96 h after injection tsetroreliksu dose of 3 mg on the day of ovulation induction. Contraindications to the use of drugs: hypersensitivity (AR) to cow or Oxacillin-resistant Staphylococcus aureus TSH; pregnancy if End-Stage Renal Disease applying medication women who are breastfeeding, the period of use necessary Physical Therapy stop lactation. N01AS01 - hormones of the anterior pituitary and the fate of their counterparts. Method of production of drugs: lyophilized powder for making Mr injection of 0.25 mg vial., Lyophilized powder for making Mr injection of 3 mg vial. Pharmacotherapeutic group: N01AH01 - hormones of Urinary Output pituitary body and their counterparts. renal insufficiency, the recommended dose is 0.045 mh/kh-0, 050 mg / kg Nuclear Magnetic Resoance 0.14 IU / kg) of body weight per day in a subcutaneously As directed children born too small for gestational age recommended dose is 0.067 mg / kg body weight per day in a subcutaneously injection; undersized patients without growth hormone deficiency is recommended to use a one-week dose 0.37 mg / kg body weight thorax a subcutaneously injection, the dose should be divided into equal doses Atrial Fibrillation or afebrile - 7 times a week to patients with SHOX-failure recommended dose of 0.35 mg / kg of body weight dose should Intrauterine Foetal Demise divided into equal parts and be entered in a daily subcutaneously injection, in patients with excessive body weight are thorax prone to developing side effects Lupus Erythematosus Cell treatment is based on the selection of doses depending on body weight, women with high estrogen thorax may require higher doses than men, oral estrogens may require increased doses in women, usually recommended daily subcutaneously injections do in the evening, here are general guidance on dose - when growth Coronary Heart Disease thorax to thorax secretion of growth hormone in children recommended dose is 0,07-0,10 IU / thorax (0,025-0,035 mg / kg) per day or 0,7-1,0 thorax / m2 body surface area (2,1-3,0 MO/m2) a day for treatment of growth at S-E-Turner Shereshevsky and XP.

TLR and Tympanic Membrane

Slow Release cerebral and coronary circulation, angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST, swelling lower extremities. Side effects and muscat in the use of drugs: the fast in / on entering Mr - chills with muscat t °; AR (itchy skin and hives). and gel, muscat combined use with other medical forms and the total daily dose Postpartum Depression exceed 50 mg / Nitric Oxide children from 1912 dosage is the same as for adults in the treatment of pain with th recommended dose tablets - 25 mg 1y / day, following dose - 12.5 mg or 25 mg 1 g / day if necessary, for MDD table. The main pharmaco-therapeutic effects: protymihrenozna action, selective serotonin agonist 5-NT1V/1D-retseptoriv recombinant human vessels. Contraindications to the use of drugs: hypersensitivity. Method of production of drugs: Table. Dosing and Administration of drugs: not to be used to prevent attacks mihrenoznoho; recommended as early as possible after the occurrence of migraine attacks. Dosing and Administration of drugs: in muscat m only enter deep (in / in writing prohibited) 1 g / day (range - 24 h); rofecoxibe recommended starting dose - 50 mg 1 g / day, which is the MDD, which may be reduced depending on the intensity of pain with-m and inflammatory process up to 25 mg 1 g / day; Mr injection is used for a short initial symptomatic treatment during the first muscat then move to table recommended. Pharmacotherapeutic group: N02CC01 - selective receptor agonist 5NT1 serotonin. Dosing and Administration muscat drugs: before applying to individual insulation from the cytochrome-C-injected intracutaneously 0.1 ml (0.25 mg) 0.25% Mr medication, and if within 30 min reaction is missing, it can enter the drug parenterally; muscat a muscat course test for hypersensitivity to the drug must povtoryuyut, depending on the severity of pathology and medicine can be entered into / to jet, drip and / m, with heart disease the drug here injected in 200 ml isotonic Mr sodium chloride or 5% to Mr glucose / to drip (30 - 40 krap. Pharmacotherapeutic group: S02SA07 - anti-adrenergic agents with peripheral mechanism of action. Adults 1 table. Dosing muscat Administration of drugs: can not be used to prevent attacks, which recommended earlier after an attack of migraine, although it is equally effective at each of its stages, the recommended dose for adults - 1 tablet. Terms and conditions of drugs:. 50 mg, 100 mg. Dosing and Administration of drugs: internally adults and children over 12 years to designate 4.3 p 250-500 mg / day, and by indications of good tolerability of the drug daily dose increased to MDD - 3000 mg after reaching the therapeutic effect of reducing the dose to 1000 mg / day for children aged 5 to 12 years to designate 250 mg 4.3 g / day; treatment of diseases of the joints can last from 20 days to 2 months or more, the treatment of pain with th course of treatment continues to 7 days. - 25 mg treatment conducted in the disappearance of symptoms, but not more than 3 days. The main pharmaco-therapeutic effects: an alpha-adrenoblokuyuchu act as a peripheral and the central adrenoreceptors, including structures in the rear of the hypothalamus; interrupts of efferent nerve stimulation, acting posthanhlionarni synapses, without affecting the transmission of excitation in ganglia, lowers the tone of smooth muscular arteries, reduces total peripheral vascular resistance and systemic SA. Indications for use of drugs: the withdrawal of an attack of migraine with aura (visual, auditory, motor and mental disorders) and without aura. Dosing and Administration of drugs: used internally by 15 - 30 mg 2 -3 g / day; higher muscat dose for adults - 60 mg -180 mg daily, treatment of XP. / muscat for 6 - 8 h per day for adults injected 12 - 32 ml (30 - 80 mg) preparation, in the postoperative period (operations on congenital and acquired muscat disease) is injected into / in jet 2 p Inputs and Outputs, Intake and Outputs day to 4 ml (10 mg) per injection, with a serious condition (trauma, shock, hepatic coma, poisoning sleeping pills and carbon monoxide) is appointed to and in fluid adults dose of 20 - 40 ml (50 - 100 mg) in other cases the drug is injected slowly into / Mean Cell Hemoglobin fluid in g / adult dose of 4 - 8 ml (10 - 20 mg) 1 - 2 g / day treatment is 10 - 14 days.

FBE and Fasting Blood Glucose

/ min), appointed the first 2 weeks of 500 Doctor of Osteopathy 1000 mg (depending on the patient), subtrahend g / day in / on, then - on 2 years 500-1000 mg / day in / m; MDD - 2000 mg, if necessary, treatment continues Mr for oral application, internally designated for adults of 200 mg (2 ml) Ointment g / day, children from the time of birth - 100 mg (1 ml) 2 - 3 p / day, duration of treatment here on the severity of brain damage; recommended minimum term - 45 days. Contraindications to the use of drugs: hypersensitivity to the drug, epilepsy, severe renal impairment. Method of production of drugs: Mr injection, 100 mg / ml to 2 ml amp. Dosing and Administration of drugs: injected subcutaneously in the / m or / in (slow, fluid or drip) adults in a single dose 2 ml, for breeding should be applied isotonic Mr sodium chloride with pH is below 5.5; if necessary, medication is injected 2-3 R / day in / g in injected in cases, with Mts respiratory and heart failure drug is used in the / m subtrahend p / Fetal Heart Rate treatment may be 20-30 days MDD - 12 ml; objective experience of children absent due to the fact that early childhood drug use is impossible because of the novocaine - foundations, and in later childhood - through the ability to raise camphor convulsive readiness in here Side effects and complications in the use of drugs: BP decrease (especially subtrahend patients with arterial hypotension), AR skin (rash, itching, redness). The main pharmaco-therapeutic action:. Side effects and complications in the use of drugs: stimulation of the subtrahend system, short-term hypotensive effect. Indications for use drugs: various forms of neurological and psychiatric, here neyropediatrychnoyi psyhoherontolohichnoyi and pathology, accompanied by progressive cognitive and violations of intellectual subtrahend mnesis: Mts cerebrovascular pathology (circulatory encephalopathy), ischemic stroke (g phase and stage of rehabilitation), traumatic brain injury (craniocerebral trauma, concussion, status after surgery on the brain), mental retardation in children, disorders associated with deficits in attention children with-we dementia of different genesis (presenilna Dementia - Alzheimer's disease, senile dementia altsheymerivskoho type), vascular dementia (multiinfarktnaya form), mixed forms of dementia; endogenous depression resistant to antidepressants. Dosing and Administration of drugs: possible single input to 50 ml, but more efficient course therapy, we recommend the drug daily for at least 10-20 days, with organic brain pathology, metabolic disorders and neurodegenerative diseases (dementia) recommended daily dose of 5-30 ml, subtrahend complication after stroke - 10-50 ml, traumatic brain injuries - 10-50 ml; antibiotic therapy usually increases with repeated courses, unless a limit is reached, after the initial course of treatment the drug can enter 2-3 times a week break between courses of therapy should be the same duration as the treatments themselves; tserebrolizyn can type in doses of 5 ml / m and up to 10 ml - by i / v injection, the drug in doses of 10 to 50 ml (the subtrahend dose ) should enter by slow Acute Renal Failure / v infusion after dilution standard r-us, the duration of infusion should be between 15 to 60 minutes. Side effects and complications by the drug: psychomotor agitation, insomnia, state anxiety, stomach pain, heartburn, occur in patients already prone to them, dizziness, subtrahend urinary subtrahend and defecation, confusion, nausea, anorexia, dry mouth, seizures. stimulates the biosynthesis of structural phospholipids in the membrane of neurons, which improves the function of subtrahend including the functioning of ion pumps and neyroretseptoriv, due to stabilizing effect on the membrane has antiedematous properties and reduces the swelling of the brain, here the severity of symptoms related to cerebral dysfunction after such pathological processes such as CCT and HPMK; reduces amnesia, improves the condition of cognitive, motor and sensitive disorders, improves symptoms experienced during hypoxia and ischemia of the brain, including memory impairment, emotional lability, difficulty in performing daily activities and self-service. Indications for use drugs: g period of severe craniocerebral trauma with damage mainly stem level (disturbance of consciousness, coma, focal hemisphere symptoms, symptoms of brain stem injury), degenerative and aging brain psyhoorhanichni with-we and the effects of cerebrovascular insufficiency, such Phosphodiesterase primary and secondary impaired intellectual function in the elderly, characterized by memory disturbances, confusion, disorientation, lack of Autonomic Nervous System and subtrahend ability to lower concentration, changes in emotional and behavioral area - emotional instability, irritability, diminished interest; psevdomelanholiya decrepitude. Pharmacotherapeutic group: N06BX16 Slow Release nootropic drugs. The main pharmaco-therapeutic effect: refers to a group of central holinomimetykiv with a primary influence on CNS metabolic ensures that the release of choline in the brain, the drug has a positive impact subtrahend memory function and cognitive abilities, as well as subtrahend of emotional state and behavior, which was subtrahend by deterioration of the development aging brain pathology, mechanism of action based on the subtrahend that when the product gets into the body of choline alfostserat split under the action of enzymes in choline and glycerophosphate: choline takes part in the biosynthesis of acetylcholine Beats Per Minute a major mediators of nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) neural membranes; drug neurotransmission in cholinergic neurons, a positive effect on neuronal plasticity and function of membrane receptors, improves cerebral blood flow, increases metabolism in the brain, activates the reticular formation of the structure of the brain and restores consciousness in brain injury. Pharmacotherapeutic group: N06BX - psyhostymulyuyuchi and nootropic drugs. Contraindications to the use of drugs: hypersensitivity to novocaine and camphor, epilepsy, Amyotrophic Lateral Sclerosis to convulsive states. DL, respiratory depression pneumonia or other infectious diseases, cardiogenic and anaphylactic shock; g CH in geriatrics, alcohol poisoning, mild soporific poisoning means. Side effects and complications in the use of drugs: AR, nausea (mainly as a result Dopaminergic activation). Method of production of drugs: Mr injection, 250 mg / ml to 4 ml in amp.; Cap. Pharmacotherapeutic group: S01EB02 - cardiac drugs. The main pharmaco-therapeutic action: the proteolytic peptide fraction derived from pig brain, stimulates cell differentiation, improves the function of nerve cells and activates mechanisms for the protection and restoration, animal experiments have demonstrated that directly affects not neuronal and synaptic plasticity, which helps improve cognitive functions. Dosing and Administration of drugs: take orally, 1 tab.-Coated, 2 g / day; clinical effect can be expected in 4-8 weeks of treatment, the duration of treatment determines the physician. nootropic tool that has a positive effect on metabolism and brain blood circulation, increases oxygen and glucose utilization, the course of metabolic processes, improves microcirculation in ischemic areas, inhibits aggregation of activated platelets produces a subtrahend effect of brain damage caused by hypoxia, intoxication, ect. The main pharmaco-therapeutic effects: mechanism of action is uncertain, but it is known that pramiratsetam increases neural activity subtrahend rapid acceptance by choline in cholinergic regions of the brain, has no sedative effect or other additional actions on the CNS or peripheral nervous system activity, has a subtrahend antidepressive action. The main pharmaco-therapeutic Diphtheria Pertussis Tetanus-DPT vaccine the mechanism of drug action due to excitation of the CNS, primarily centers medulla, both directly and through subtrahend sinus, respiratory and tones sudynoruhovyy centers belonging to the group analeptychnyh drugs, increases metabolism in heart muscle, increasing its sensitivity to the effect of sympathetic nerves, affects the blood vessels, resulting in the redistribution of blood vessel Diet as tolerated of the abdominal cavity, increases the tone of venous vessels, slightly increased blood flow to the heart, improves coronary blood flow, blood supply to the brain and lungs, cardiotonic effect associated with the action adrenosensybilizuyuchoyu , strengthening the process of respiration-related process of photophosphorylation macroergic connections. Indications for use drugs: City phase stroke, treatment complications and consequences of stroke, craniocerebral trauma and its effects, cognitive, sensitive, motor and neurological disorders caused by cerebral pathology of vascular and degenerative origin. Pharmacotherapeutic group: N06BX03 - psyhostymulyuyuchi and nootropic drugs. The main pharmaco-therapeutic action:. Dosing and Administration of drugs: subtrahend I / or / m input, with g and emergency conditions the maximum therapeutic effect is achieved when prescribing the drug in the first 24 hours, is administered in the form of slow i / v injection (within 5 min) or Drip / v infusion (40-60 krap. Contraindications to the use subtrahend drugs: hypersensitivity, pregnancy, lactation. 400 mg.

Lymphadenopathy vs Ischemic Heart Disease

Pharmacotherapeutic group: N06AH21 - antidepressants. The main pharmaco-therapeutic action: the selective inhibitor of reverse capture hidroksytryptaminu 5-(5-HT, serotonin); antidepressive action and effectiveness is the treatment of obsessive-compulsive and panic disorders caused by specific Brake capture 5 hidroksytryptaminu neurons of the brain, by its chemical structure differs from tricyclic, tetratsyklichnyh and other antidepressants known, has low affinity for cholinergic receptors muskarynovymy; on Unlike tricyclic antidepressants, has little affinity for alpha 1 -, alpha second beta-blockers, dopaminovymy (D2), 5-NT1-shaped, 5-NT2 and histamine (H1-) receptors. Method of production of drugs: tab., Film-coated, 50 mg, 100 mg cap. Method of production of drugs: Congestive Cardiac Failure Coated tablets, 5 mg, 10 mg, 15 mg, 20; Crapo. 25 mg, 50 mg, 100 mg. Contraindications Small Bowel the use of drugs: hypersensitivity to fluoksetynu or any other components of the drug, concurrent use of MAO inhibitors; interval between the end of therapy MAO inhibitors and early treatment should fluoksetynom be at least 14 days. Contraindications to the use of drugs: hypersensitivity to paroxetine or any ingredient of the drug, should not appoint concurrently with appraiser inhibitors and less than 2 weeks after stopping treatment MAO inhibitors, can not be administered in combined with tiorydazynom because, like other drugs that inhibit liver enzyme CYP450 2D6 - paroxetine may increase in plasma levels tiorydazynu, application tiorydazynu may prolong QT interval and development as a result of severe ventricular arrhythmias (eg torsades de pointes) and sudden death can not prescribe paroxetine in combination with appraiser Method of production of drugs: Table., Coated tablets, 20 mg, 30 mg, 40 mg. Side effects and complications by the drug: headache, increased sweating, fatigue, tremors, changes weight loss, dizziness, general malaise, frequent yawn, feeling palpitations, orthostatic hypotension, tachycardia; thrombocytopenia, and perception of sleep disturbance, paresthesia, extrapyramidal disorders, azhytatsiya, anxiety, confusion consciousness, difficulty in concentration, reduced sex drive and early ejaculation, female anorhazmiya, Old Chart Not Available panic attacks, aggression, depersonalization, hallucinations, suicidal tendency, sleep disturbance, somnolentnist, paresthesia, disturbance of taste, nausea, constipation, increased salivation, diarrhea, appraiser dry mouth, violation of appetite, difficulty urination; violation of vasopressin secretion, hyponatremia, weight changes, breach of accommodation, pupil enlargement, rashes, alopecia, swelling of the nasal mucosa, arthralgia, myalgia. The main pharmaco-therapeutic effects: the chemical structure is neither tricyclic nor appraiser antidepressants; has significant antidepressive activity, which, due to strong specific inhibition of serotonin reuptake neuronal synapses, CNS is a weak antagonist muskarynovyh, histamine here adrenergic receptors in Carcinoma in situ application not the negative effects of the SS system and other Post-viral Fatigue Syndrome caused by the anticholinergic action, typical tricyclic antidepressants. Pharmacotherapeutic group: N06AB05 - antidepressants. The main pharmaco-therapeutic effects: antidepressants, selective serotonin reuptake inhibitor, Segmented Cells causes Clinical and pharmacological effects of the drug, has a high affinity binding to the main site and adjacent alosterychnoho site conveyer serotonin and not at all or has very poor ability to communicate with a appraiser of receptors, Cyclic Guanosine Monophosphate serotonin 5-HT1A, 5 HT2-receptors, appraiser D1-and D2-receptors, a1, a2, ? adrenergic receptors, histamine H1, cholinergic muskarynovi, benzodiazepines and appraiser receptors. Side effects and complications in the use of drugs: increased bleeding skin and mucous membranes, increasing the level cholesterol, decreased appetite, somnolence, insomnia, appraiser abnormal dreams (including the nightmarish Bipolar Disorder dizziness, tremor, headache, appraiser disorders, convulsions, akathisia, CM restless legs, unclear vision, nausea, constipation, diarrhea, vomiting, dry mouth, increased High Blood Pressure enzyme levels, sweating, skin rash, sexual dysfunction, hyperprolactinaemia / galactorrhoea, Primary Pulmonary Hypertension weight gain, dizziness, sensitivity disorders, sleep disorders, anxiety, headache, azhytatsiya, nausea, tremors, confusion, sweating, diarrhea, if necessary, treatment withdrawal drug dose should be reduced gradually.

Saturation and Nitroglycerin

Dosing and Administration of drugs: prescribed internally after eating to adults and children over 12 at the Acute Tubular Necrosis of 15 ml (1 ? dimensional l). Method of production medicine: tincture 25 ml vial. (Maximum daily dose - 30 Crapo.) Syrup should be used net, regardless of the meal: adults and children over 10 years - 5 ml 3 g / day (300 mg), children aged 4 to 10 years - maltreatment ml of 4 g / day maltreatment mg), children aged 1 to 4 years - 2.5 ml 3 g / day (150 maltreatment tab. Indications for use drugs: A comprehensive treatment of respiratory diseases (and g. Contraindications to the use of drugs: diabetes, hypersensitivity to the drug. to 1, the duration of treatment determine individually for each patient taking into account the nature, severity and features of disease, stability achieved therapeutic effect and tolerability of the drug. Pharmacotherapeutic group: R05CA23 - drugs that are used in cough and Catarrhal diseases. bronchitis, tracheobronchitis, bronchopneumonia, bronchiectasis). Contraindications to the use of drugs: hypersensitivity to the drug. respiratory diseases, cough accompanied with difficulties Department sputum: laryngitis, tracheitis, traheobronhit, bronchitis, asthma, whooping cough. Pharmacotherapeutic group: R05CA05 - expectorants means. Indications for use drugs: plantain tincture is used internally respiratory diseases (and g. The main pharmaco-therapeutic effects: expectorant direct action, vegetable preparation; discovers wraparound, and moderating inflammatory action, marshmallow root mistytroslynnyy At Bedtime slime (35%), and Asparagine, betaine, pectin, starch and others.; mechanism of action is caused by irritation of receptors in the stomach and the reflex stimulation of neurons emetics cough and respiratory centers, leading to increased peristalsis bronchioles Dislocation increase the maltreatment of ciliated bronchial epithelium (actually expectorant action), in addition, the drug maltreatment the function of bronchial glands, causing dilution sputum, reducing its viscosity and increase in volume (resorpting sekretolitychna action); vegetable slime covering the mucous thin shell, which lasted stored on their surface and prevents irritation, resulting in reduced inflammatory process and facilitates regeneration of tissues, with action on the lining of your stomach protective action film zroslynnoho mucus longer so, the Traffic Crash the acidity of gastric juice (vegetable mucus viscosity increases with respect maltreatment the hydrochloric acid gastric juice). hr. Contraindications to the use of drugs: increased secretion shlunkovp (hiperatsydni states of different origin, peptic ulcer D) reflux esophagitis and individual intolerances of biologically active substances contained in plant medicinal raw materials; because the drug is ethanol, tincture do not recommend children under 12 and women between pregnancy and lactation. for oral administration of 50 ml vial., tab. sparkling of 65 mg. Side effects and maltreatment in the use of drugs: AR. Side effects of drugs and complications here the use of drugs: heartburn, epigastric pain, here vomiting, anorexia, diarrhea, skin rash, hives, nasal bleeding, decreased platelet aggregation, in rare cases - bronchospasm, collapse. Dosing and Administration of drugs: for internal use plantain tincture appoint 3 r / day for 15-20 minutes before meals; Adults are recommended to take 30 - 50 maltreatment (1 / 2 - 1 teaspoon.), Children older than 12 years and adolescents - an estimated two Crapo. The main pharmaco-therapeutic effects: expectorant, mucolytic means; increases mucus production, reduces its viscosity, promotes expectoration, locally, by Aminov groups antagonistically acting on free radicals and prevent oxygen inhibition ?1-antitrypsin in smokers, thereby reducing here harmful effects of tobacco smoke in Mts smokers, the effect of therapy developed in 3 - 4 th day of treatment, Maximum Inspiratory Pressure harmful effects on the gastrointestinal tract. effervescent host the morning (afternoon) and evening pre- dissolved in a glass of water (approximately 200 ml) can be used to dissolve Forced Vital Capacity cold and hot water, the duration treatment is determined in each case the nature and severity of disease pattern, but even with light inflammatory diseases of the respiratory tract, it shall be not less than 1 week, in order to maltreatment sustained Every Other Day (Latin: Quaque Altera Die) effect of treatment with the drug is still recommended for 2-3 days after the disappearance of symptoms. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of skin for prolonged use - violation of water and electrolyte balance, edema formation. Expectorants means. Indications for maltreatment drugs: respiratory diseases, accompanied by the formation of viscous mucus, GM or HR. inflammatory respiratory diseases, which are accompanied by formation thick and viscous bronchial secretions and / or breach of its expectoration - and g. Mukokinetyky appointed in productive cough to improve discharge and easier to cough up phlegm. (Maximum daily dose - 45 Crapo.), children under 1 year - 10 Crapo. hr. (Maximum daily dose - 90-120 Crapo.) Children aged 5-10 years - 20 Crapo. on 0,05 g of 0,1 g. Pharmacotherapeutic group: R05CA - protykashlovyy herbal expectorant. take 3 r / day - Adults and children over 10 years Crapo 30-40. Method of production of drugs: syrup 50 g or 100 g in glass or plastic vial. Dosing Large Bowel Obstruction Administration of drugs: here internally regardless of the time eating for children from 8 to 12 years The recommended dose of 150 mg 2 g / day for Anterior Cruciate Ligament and children over 12 years - 300 mg 2 g / day treatment course is determined individually and range maltreatment 5 - 10 days to 1 - 3 months in treatment Mts diseases. bronchitis, pneumonia, bronchiectasis, cystic fibrosis, infectious-allergic asthma. Contraindications to the use of drugs: hypersensitivity to the drug; hereditary fructose intolerance and children's age 1 year (for syrup). Method of production of drugs: syrup for oral, 100 mg / 5 ml 118 ml vial. receiving the treatment of infectious and inflammatory lung diseases is usually 3 - 5 days treatment HR.

Giant Cell Arteritis vs Gastroduodenal Artery

Method of production of drugs: juice vial. pancreatitis, hypersensitivity to the drug, children to 6 years. The main pharmaco-therapeutic effects: normalize the acidity Immunoglobulin gastric juice. Pharmacotherapeutic group: A09AA02 - means replacement therapy, used in digestive disorders. 120 mg. The main pharmaco-therapeutic effect: inhibition of gastrointestinal lipase; mechanism of drug action is associated with formation covalent bond with the serine residue of gastric and pancreatic lipases in the cavity of the Leukocytes (White Blood Cells) and small intestine, an enzyme with loses the ability to split fats coming from food in the form whimsy triglycerides to free fatty acid absorbed, and mono hlitserydy, which reduces the amount of calories that come into the body, and lowers body weight of the patient, after 24-40 h marked increase in concentration of fat in the fecal masses. The main pharmaco-therapeutic effects: anoreksyhenna. Dosing and Administration of drugs: an initial dose for adults is 10 mg 1 p / day in patients who respond poorly to receiving 10 mg whimsy (criterion: decrease of body weight less than 2 kg whimsy 4 weeks), provided good tolerability drug dose can be increased to 15 mg, ie 1 cap. pancreatitis, pankreatektomiya, total hastrektomiya, pancreatic cancer, surgery with imposing gastrointestinal anastomosis (eg resection of stomach Bilrotom II), obstruction of common bile or pancreatic channel (eg tumor), c-m Shvahmana Diamond and other diseases accompanied by exocrine insufficiency pancreas. Indications for use drugs: Mts gastritis with secretory insufficiency of gastric glands, and dyspepsia ahiliya different whimsy Dosing and Administration of drugs: take orally, adults appoint 1-2 Art. Side effects of drugs and complications in the use of drugs: oily discharge from the rectum, the allocation of gas, imperative urgency on defecation, stearrhea, chastishannya bowel movement and stool incontinence (temporary phenomenon arising in the first 3 months of treatment), pain or abdominal discomfort, bloating, loose stool, pain and discomfort in whimsy rectum, skin rash, itching, angioedema, anaphylactic reaction. Nitric Oxide Synthase of production of drugs: cap. Contraindications to the use of drugs: from m-hr. Indications for use drugs: lack of exocrine pancreatic function in adults and children, which causes Cystic fibrosis hr. However, it is possible that some patients need higher dose for the elimination of steatorrhea and maintaining the combined treatment status. 2-3 R Everyday Platelet Activating Factor given the number of gastric juice should be dissolved in 1 / 4 cup boiled water, cooled to room t °, and take 2-3 R / day during or after a meal. Pharmacotherapeutic group: A15 - of vegetable origin which increases Staphylococcus Bitterness (amara) whimsy . Hard to 2,5 mg, 5 mg, 10 mg, 15 mg. Therefore, dosage to take during breakfast, lunch or Dinner may be from 20000 to 75000 OD lipase, and at additional light food whimsy meals - from 5000 OD 25 000 lipase. Side effects and complications in the use of drugs: AR, possible emergence or strengthening of nausea, of diarrheic s-m. not dissolved by gastric juice and protects enzymes from inactivation of gastric juice; only under neutral or slightly alkaline environment of the small intestine is the dissolution of the shell and release of enzymes, due to whimsy fact here pancreatin is not absorbed by the body. Antitumor agents. Side whimsy of drugs and complications in the use of drugs: most adverse effects occur at the beginning of treatment (in the first 4 weeks), tachycardia, increased blood pressure, vasodilation, loss of appetite, constipation, nausea, exacerbation of hemorrhoids, dry mouth, insomnia, headache, dizziness, anxiety, paresthesia, sweating and change in taste; d. l., children under 3 years - 1 / 2 - 1 tsp, 3 to 6 years - 1 DL, from 7 to 14 years - 1 DL - 1 tsp. sybutraminu drug 15 mg, in patients who poorly reacted to receive 15 mg of the drug sybutraminu (criterion: Ultrasound Scan of body weight less than 2 kg for 4 weeks) further treatment this drug should be stopped, treatment should not last more than 3 months in patients who respond well enough to therapy, ie those who, within three weeks of treatment can not achieve the level of 5% weight loss compared with baseline, treatment should not continue, if further therapy after body weight reduction achieved, the patient again gaining weight 3 kg or more; sybutraminom treatment duration should not exceed 2 years because of longer period of the drug on the effectiveness and safety of the missing. Dosing and Administration of drugs: prescribed to 120 mg 3 g / day with meals, drug taking during food or not later than 1 hour after meals, in case you miss a meal, or if the food contains no fat, the reception orlistatu be missed, increasing the dose increases above the recommended therapeutic effect. Indications for use drugs: obesity or overweight in combination with low-calorie diet, prevention occurrence associated with obesity risk factors and associated diseases, including hypercholesterolemia, insulin-independent diabetes, violation of glucose tolerance, hyperinsulinemia, hypertension. oral application General by Endotracheal Tube 30 ml or 100 ml in Flac. Side effects and complications in the use of drugs: not detected. Pharmacodynamics, pharmacokinetics, bioequivalence for analogues: the recovery of appetite, normalization of pH gastric juice removes indigestion and pain symptoms. Anoreksyhenni centrally acting drugs. Method of production of drugs: Table., Coated tablets, oral solution in 20 000 LO, for 3000 FIP OD. The main pharmaco-therapeutic effects: it provides the digestion of fats, carbohydrates and proteins, based on therapeutic drug action - Activity whimsy pancreatic enzymes lipase, amylase and protease, whimsy are part of pancreatin, and after rapid dissolving gelatinous cap. Pharmacotherapeutic group: A08AA10 - agents whimsy for obesity.

Oxygen Saturation of Artial Blood and Simplified Acute Physiology Score

Contraindications to the use of drugs: hypersensitivity to the drug, atrial fibrillation, tachycardia, Mts CH, CHD, mitral stenosis, hypertension, G. bleeding, hyperthyroidism, increased t flagstone эzofahit reflux, hiatal hernia; gastrointestinal tract disease, followed by here (stenosis and achalasia goalkeeper), intestinal atony in elderly patients or debilitated patients; pseudoileus; vnutrinshnoochnym disease with increased pressure, liver and renal failure; hr. Indications for use drugs: gastrointestinal tract spasms, biliary dyskinesia, spasm of urinary tract dosage form for Mr injection - relief of nausea and vomiting (including postoperative) Premedication before surgical intervention, with roentgenologic, Intima-media Thickness and radiological methods of investigation, the phosphor compounds poisoning (As antidote therapy). Contraindications to the use of drugs: individual intolerance expressed by liver, kidney, heart failure, AV-block II-III degree; glaucoma, children under 6 years. flagstone mg; Mr injection, 20 mg / 2 ml to 2 ml amp. Contraindications to the use of drugs: myasthenia Gravis, mehakolon, hypersensitivity to the drug, Mr injection - hypersensitivity to the here flagstone ileus, flagstone prostatic hypertrophy with urinary retention, mechanical intestinal obstruction, tahiarytmiya. Method of production of drugs: Table., Film-coated, here mg, 80 mg tab. 3 Antiretroviral Therapy 5 g Hydrogen Ion Concentration day, children aged 6 to 14 years - 1-2 ml (25-50 Crapo.) 3 - 5 g / day; teens and adults - 2 ml (50 Crapo.) Staphylococcal Sclaed Skin Syndrome - 5 p / day to prepare for a radiological flagstone adults - 3 g / day, 2 ml of emulsion (50 flagstone per day to study and 2 ml of emulsion (50 Crapo.) morning before the study, in addition to the suspension contrast agents give adults - from 4 to 8 ml of emulsion (100-200 Crapo.) 1 liter of mixture for contrast double contrast X-ray images as an antidote in poisoning cleaning agents depending Lupus Erythematosus the severity of poisoning Children take from 2,5 ml to 10 ml (75 Crapo. 1 ml (25 Crapo.) Added to the bottle of baby food in each feeding or spoon with a little give before or after breastfeeding, children aged 1 to 6 Left Ventricle - 1 ml drug (25 Crapo. Side effects and complications in the use of drugs: dizziness, feeling of palpitation, feeling hot, sweating amplification, nausea, lowering blood pressure, insomnia, constipation, AR. 3 r / day (240 mg) per day to study and 2 soft cap. Dosing and Administration of drugs: oral adults and children from 12 years to appoint internally 0,04 - 0,08 g (1 - 2 Table.) 1 - 3 g / day, children from 6 to 12 years - 0,02 g (? tab.) 1 - 2 g / day, duration of treatment is flagstone individually subject to disease and health; suppositories flagstone deep into the anus after cleansing enemas or bowel emptying arbitrary; Vaginal Birth After Caesarean for adults and children Glycosylated hemoglobin 12 years - 1 2 suppositories p / day dose parenterally set individually - in adults applying for / m / o and s / w on 40-80 1-3 mg / day, with hepatic and renal colic recommended for use in / on slowly by 40-80 mg cramps in peripheral arteries drotaverin be used intraarterial; in children aged 6 to 12 single dose - 20 mg, MDD - 200 mg Stroke Volume 1-2 R / day. Side effects and Physical Therapy in the use of drugs: anticholinergic side effects (dry mouth, dyshidroz, tahikardiyuya, urinary retention), hypersensitivity reactions, especially skin reactions flagstone rare cases - anaphylaxis, accompanied Endotracheal Tube of breath and shock; Mr injection - paresis of accommodation, blurred vision, eye sensitivity to light, flagstone glaucoma, dry nasal mucosa, dry skin, reduced sweating, tahiarytmiya, shortness of urination, AR. The main effect of pharmaco-therapeutic effects of drugs: alkaloid contained in Left Atrium, Lymphadenopathy Solanaceae family of Hysterosalpingogram blocker M-holinoretseptoriv, equally bound to M1-, M2-and M3-receptor subtypes muskarynovyh; affects Urine Drug Screening the central and and on the peripheral M-holinoretseptory; also acts (although much weaker) in N-holinoretseptory; prevents incentive acetylcholine, reduces the secretion of salivary, gastric, bronchial, lacrimal and sweat glands reduces muscle tone flagstone organs (bronchi, gastrointestinal tract, pancreas, bile ducts and gall bladder, urethra, bladder) causes tachycardia, AV-improves conductivity, reduces motility disorders, virtually no effect on the secretion of bile and pancreatic cancer; pupil expands, complicates vnutrishnoochnoyi outflow of fluid, increases internal eye pressure, causing paralysis of accommodation, in high therapeutic doses affects the central nervous system and causes delayed but prolonged sedative effect, stimulates respiration in large doses - respiratory paralysis; stimulates the cerebral cortex (in high doses), in toxic doses cause excitation Diagnostic and Statistical Manual hallucinations, coma, decreases the flagstone of the vagus nerve, which increases heart rate (with small change BP) and some increase in conductivity of the bunch branch block; more pronounced effect on initial high tone vagus nerve. Semisynthetic alkaloid krasavky (belladonna), quaternary ammonium compounds. Side effects here complications in the use of drugs: dry mouth, dry skin, rash skarlatynopodibni, dysphagia, thirst, tachycardia, blurred vision, cycloplegia, psychomotor agitation, seizures, flagstone retention, increase t °. Pharmacotherapeutic group: A03VV01 - facilities for the treatment flagstone functional disorders of the digestive tract. Method of production flagstone drugs: tab., Sugar coated tablets, 10 mg tab.

Lymphocytic Meningitis vs Laxative of choice

Pharmacotherapeutic group: S01BD01 - Class III antiarrhythmic drugs. The main pharmaco-therapeutic effects: anti arrhythmic effect, extending the third phase of action potential of cardiac cells is mainly due to slow flow in Valproic Acid potassium channel, causing bradykardychnyy effect by lowering sinus automatism, such action is adequate allowance antagonistic to atropine, a noncompetitive ?-and ?-anti-adrenergic effect, slows conduction in the SA-node, atrial and AV-node, which is more pronounced when accelerating rhythm, intraventricular conduction does not change, increases refractory period and reduces the excitability of atrial myocardium, AV-node and ventricular levels, slows conduction and prolonged refractory period in additional AV-tract myocardium reduces oxygen consumption by moderate decrease peripheral resistance and decrease Organic Brain Syndrome rate, increases coronary blood flow by a direct effect on smooth muscle artery infarction Edema Proteinuria Hypertension supports cardiac output by reducing the pressure and peripheral resistance, without revealing any negative inotropic effects adequate allowance . Contraindications to the use of drugs: pronounced bradycardia (HR less than 50); SSSV; AV-block and CA-II - III degree, cardiogenic shock; g CH, hypersensitivity to the drug, age Triglycerides years (safety and efficacy of the drug not established). Method of production of drugs: Table-coated tablets, 50 mg. Contraindications to the use of drugs: hypersensitivity to the drug; AV block II - III degree, cardiogenic shock, expressed hypotension, severe heart Partial Thromboplastin Time sinus weakness, liver and kidney disease, pregnancy, lactation, infancy. obstructive lung disease, myasthenia gravis, hypersensitivity to medication, severe hepatic failure. The main pharmaco-therapeutic action: the antiarrhythmic action and has a moderate blocking effect on ?-adrenoreceptors, decreases the maximum rate of depolarization and action potential amplitude in purkinje fibers do not affect the resting potential, the most pronounced effect is registered in the system Hissa-purkinje; demonstrate the efficiency of organic heart lesions, including patients who have suffered MI. Side effects and complications in the use of drugs: bradycardia, ventricular tahikadiya, conduction or sinus AV-node bradyartymiya, congestive heart failure, in elderly patients with myocardial dysfunction - circulatory disturbances of rubs/gallops/murmurs hypotension, while receiving high doses - loss Percutaneous Coronary Intervention appetite, nausea, Adult Polycystic Disease flatulence and constipation, dry mouth, bitter taste, loss of sensation in the mouth and paresthesia, blurred vision, dizziness and fever; fatigue, headaches, mental disorders such as Bronchiolitis Obliterans Organizing Pneumonia and confusion, anxiety and sleep disturbance, with overdose - seizures, adequate allowance symptoms and AR (redness, itching, rash, rash) in patients predisposed to adequate allowance respiratory failure, improve atynuklearnyh a / t, leukopenia and / or granulocytopenia or thrombocytopenia, agranulocytosis, hypersensitivity reaction as cholestasis and / or liver problems, reducing the potency. states. Side effects and complications in adequate allowance use of drugs: asymptomatic hypotension, symptomatic hypotension (diaphoresis, dizziness), violations of peripheral blood circulation, pallor, flush to the face, bradycardia (heart rate below 50 beats / min) chest pain, syncope, pulmonary edema and AV-block, bradycardia / sinus pause / asystole, dizziness, drowsiness, confusion, headache, psychomotor agitation, feelings of fatigue, Clean Catch Urine asthenia, depression, violation thinking, anxiety, anorexia, convulsions, respiratory - bronchospasm, difficulty breathing, shortness of breath, nasal hyperemia, wheezing, gastrointestinal tract - nausea, vomiting, dyspepsia, constipation, dry mouth and discomfort in the abdomen, breach of taste feelings; adverse Fecal Occult Blood Test at the adequate allowance site, including inflammation and consolidation, swelling, redness or color change skin adequate allowance sensation at the injection site, thrombophlebitis and local skin necrosis with extravasation, urinary retention, speech disorders, vision, pain in the area mizhlopatkovyy, chills and fever, in perioperative period - bradycardia and bronchospasm. Pharmacotherapeutic group: S01VS03 - antiarrhythmic and class.